Results from a phase 2 clinical trial showed that treatment with an IgG-cleaving enzyme for individuals diagnosed with Guillain-Barré syndrome led to faster muscle strength recovery and mobility ...

Gaza has recently seen a surge in Guillain-Barre syndrome, which can cause full-body paralysis in extreme cases.

The European Task Force unveils critical updates on Guillain-Barré syndrome, highlighting new treatment strategies and diagnostic criteria for clinicians.

Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome. That's welcome news.